Robert A. Figlin
- Cancer Research top 0.02%
- Cancer Genomics and Diagnostics 126
- Pulmonary and Respiratory Medicine top 0.01%
- Renal cell carcinoma treatment 289
- Oncology top 0.05%
- Cancer Immunotherapy and Biomarkers 63
- CAR-T cell therapy research 27
- Molecular Biology top 0.05%
- Renal and related cancers 147
- Immunology top 0.5%
- Immunotherapy and Immune Responses 39
-
- Bladder and Urothelial Cancer Treatments 52
-
- Economic and Financial Impacts of Cancer 31
- Co-authors
- Arie S. BelldegrunRobert J. MotzerThomas E. HutsonStéphane OudardAllan J. PantuckRonald M. BukowskiPiotr TomczakM. Dror Michaelson
- Journals
- Journal of Clinical Oncology (106 papers)The Journal of Urology (60 papers)Cancer (28 papers)
- Partner nations
- United StatesFranceCanada
In The Last Decade
Robert A. Figlin
465 papers receiving 37.1k citations
Hit Papers
Peers
Comparison fields: 5 of 164
- Cancer Research 12.1k
- Pulmonary and Respiratory Medicine 25.4k
- Oncology 12.1k
- Molecular Biology 22.0k
- Immunology 3.2k
Countries citing papers authored by Robert A. Figlin
This map shows the geographic impact of Robert A. Figlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Figlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Figlin more than expected).
Fields of papers citing papers by Robert A. Figlin
This network shows the impact of papers produced by Robert A. Figlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Figlin. The network helps show where Robert A. Figlin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert A. Figlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 9 | |
| 3 | 2020 | 53 | |
| 4 | 2020 | 9 | |
| 5 | 2020 | 3 | |
| 6 | 2019 | 13 | |
| 7 | Highlights in kidney cancer from the American Society of Clinical Oncology Genitourinary Cancers Symposium. | 2017 | 1 |
| 8 | Circulating tumor cells in prostate cancer: beyond enumeration. | 2017 | 9 |
| 9 | 2014 | 30 | |
| 10 | 2014 | 56 | |
| 11 | 2011 | 93 | |
| 12 | 2010 | 99 | |
| 13 | 2010 | 110 | |
| 14 | Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinomabreakdown → | 2009 | 1711 |
| 15 | 2009 | 3 | |
| 16 | Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trialbreakdown → | 2008 | 2339 |
| 17 | Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinomabreakdown → | 2005 | 1304 |
| 18 | 2005 | 118 | |
| 19 | 2003 | 30 | |
| 20 | 1999 | 71 |
About Robert A. Figlin
Robert A. Figlin is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 470 papers that have together received 38.0k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (289 papers), Renal and related cancers (147 papers), Cancer Genomics and Diagnostics (126 papers), Cancer Immunotherapy and Biomarkers (63 papers), Bladder and Urothelial Cancer Treatments (52 papers), Immunotherapy and Immune Responses (39 papers), Economic and Financial Impacts of Cancer (31 papers) and CAR-T cell therapy research (27 papers). The work is most often cited by research in Cancer Research (12.1k citations), Pulmonary and Respiratory Medicine (25.4k citations) and Oncology (12.1k citations). Robert A. Figlin has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Arie S. Belldegrun, Robert J. Motzer, Thomas E. Hutson, Stéphane Oudard, Allan J. Pantuck, Ronald M. Bukowski, Piotr Tomczak, M. Dror Michaelson, Sindy T. Kim and Sylvie Négrier. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Urology, Cancer, Clinical Cancer Research and Journal of Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.